Delivery Order SPE2DB24D2003-SPE2DB25FXLP8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This firm fixed price delivery order, valued at $16,053.06, represents a non-set-aside competitive award with an ultimate completion date of September 22, 2025. The pharmaceutical products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 units. This contract, valued at $17,672.24, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was awarded through open competition. The ultimate completion date is set for September 30, 2025, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,418.06 and an ultimate completion date of September 4, 2025. The award was made through open competition with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside delivery order has a ceiling value of $8,026.53 with a firm fixed price structure and an ultimate completion date of September 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $8,026.53 and an ultimate completion date of September 17, 2025. The contract involves no set-aside designation and was competitively awarded. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania serves as both the place of performance...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of approximately $8,027 and is structured as a firm fixed price delivery order, with an ultimate completion date of October 20, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 tablets, with a contract ceiling value of $13,254.18. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 9, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. The contract has a ceiling value of $8,026.53 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 15, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award carries no set-aside designation, indicating it...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Promacta 50 mg tablets (30-count units) with a ceiling value of $8,026.53. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract vehicle with the DLA. The award was competitively awarded with no set-aside designation and will be performed at...
- The Defense Logistics Agency awarded a $24,059.26 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded delivery order with an ultimate completion date of October 9, 2025. The contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXLP8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order valued at $8,026.53, with performance completion scheduled for September 3, 2025. The contract involves no set-aside designation and represents a competitive award to the prime contractor. Performance will occur at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a broad range of pharmaceutical products and medical commodities to support military and federal healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. The company's consistent receipt of competitively awarded delivery orders across multiple therapeutic domains demonstrates its capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 8/12/25 |